NDC 63323-413-01 - Neostigmine Methylsulfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-413
- Requested NDC
- 63323-413-01
- Package NDCs from labels
- 63323-413-36, 63323-413-01, 63323-413-10
- Manufacturer
- Fresenius Kabi USA, LLC
- Effective date
- 2024-10-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Neostigmine Methylsulfate - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-10-15 | HUMAN PRESCRIPTION DRUG LABEL |
| Neostigmine Methylsulfate - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2022-12-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-413-01 | Neostigmine Methylsulfate | 10 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 10 | 4 | |
| 63323-413-10 | Neostigmine Methylsulfate | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | 4 | |
| 63323-413-36 | Neostigmine Methylsulfate | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | 3 | |
| 63323-413-36 | Neostigmine Methylsulfate | 10 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 10 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-413 | NEOSTIGMINE METHYLSULFATE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 4 | Current NDC, Legacy NDC, 2 package rows | 20221217_6448229c-e650-47ba-bb00-cba3604502c5.zip |
| 63323-413 | NEOSTIGMINE METHYLSULFATE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | Current NDC, Legacy NDC, 2 package rows | 20241020_d0e11e4c-41c3-4874-b567-579db655fba3.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-413-10 | ML - Milliliter | 63323-413 | 6a6ee13a-ac87-45ce-bdf7-6cbc53582771 | 1 | 2015-03-03 |
| 63323-413-36 | ML - Milliliter | 63323-413 | 259824c1-d243-4db2-a3e2-36e20fbbe8cd | 1 | 2016-08-09 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a2b9456-8ca0-8253-e053-2a95a90a8f12 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a2a34f9-ed95-9921-e053-2995a90a0d59 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a2bc45d-e0c8-3af2-e053-2a95a90af0f1 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a67169d-6b15-3406-e053-2995a90a60e4 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a673225-27be-040a-e053-2a95a90a0a98 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a66b61d-82bd-2bbb-e053-2995a90a0b58 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a677063-09d2-8052-e053-2a95a90affae | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a678fac-289c-0f5c-e053-2995a90a0f43 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a66da0b-ee7b-2b69-e053-2995a90ae951 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a667d80-d05c-2d18-e053-2995a90a2918 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a66e2a9-a661-e847-e053-2a95a90aa304 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a67a0bb-6943-2f5f-e053-2a95a90aac6e | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a6711a9-e0a4-9083-e053-2a95a90ad4a4 | 2025-01-09 | Q40Q9N063P | |
| Acidum Aceticum | ACIDUM ACETICUM | Hahnemann Laboratories, Inc. | 9a67bb27-cb44-4a1d-e053-2a95a90a0ee2 | 2025-01-09 | Q40Q9N063P | |
| STERILE WATER | STERILE WATER | HF Acquisition Co. LLC, DBA HealthFirst | 74ed2a6f-824c-a1ff-e053-2a91aa0a57c0 | 2025-01-09 | Warnings, Adverse reactions | 059QF0KO0R |
| STERILE WATER | STERILE WATER | HF Acquisition Co LLC, DBA HealthFirst | 77bd3c0f-f4ab-7cfa-e053-2a91aa0a1b83 | 2025-01-09 | Warnings, Adverse reactions | 059QF0KO0R |
| STERILE WATER | STERILE WATER | HF Acquisition Co LLC, DBA HealthFirst | 7610bf80-61b7-982f-e053-2a91aa0ac1bb | 2025-01-09 | Warnings, Adverse reactions | 059QF0KO0R |
| T-27 | WATER | DNA Labs, Inc. | f0e9afd7-64a4-4b85-9c5f-4bf07ba4b481 | 2025-01-09 | Warnings | 059QF0KO0R |
| Sterile Water | STERILE WATER FOR INJECTION | Medefil, Inc. | 99e99a50-82d5-aff6-e053-2a95a90a8c56 | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
| BACTERIOSTATIC WATER | BACTERIOSTATIC WATER | HF Acquisition Co LLC, DBA HealthFirst | 99b0ef9b-600a-40dc-e053-2a95a90aa07e | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.